Viz.ai Powers Pharma CRM Triggers

This integration turns Viz.ai from a point solution inside hospitals into a data supplier inside pharma’s daily CRM workflow. Instead of asking drug companies to buy and learn a separate product, Viz.ai pipes live clinical signals into the Salesforce system that brand teams, field reps, medical science liaisons, market access teams, and patient support teams already use, which makes hospital level patient finding easier to operationalize at scale.1 2 3 4

• Viz.ai already sits in the clinical workflow. Its software reads scans, flags suspected disease, and alerts care teams on mobile. With deployment across nearly 2,000 hospitals and 230 million covered lives, the connector lets those triggers move from the bedside into pharma outreach and patient support systems without a manual handoff.1 2
• Salesforce is building Agentforce Life Sciences as a shared operating layer for clinical, medical, commercial, and patient services teams. Viz.ai fits because its data is event driven, a new diagnosis, a care transition, a high risk patient, which is exactly the kind of signal a CRM can route into next best actions for launches, adherence, and field team follow up.3 4 5 6
• The business model implication is that Viz.ai can monetize the same hospital footprint twice. Hospitals pay subscription fees for care coordination software, then pharma pays for access to workflow integrated patient identification and launch support. That helps explain why Viz.ai expanded to 13 life sciences partnerships after adding 6 new pharma partners in 2025.1 2

From here, the prize is becoming the default clinical trigger layer for life sciences teams, not just another AI app. If Viz.ai keeps adding disease specific workflows and more pharma partners, its hospital network becomes more valuable as a distribution channel for launches, patient services, and trial recruitment, which should deepen switching costs on both the provider and pharma sides.1 2 3